---
$id: https://graph.org.ai/products/commodity/51401548
$type: Product
source: UNSPSC
code: "51401548"
title: "Reclazepam"
class: "51401500"
classTitle: "Tranquilizers and antimanic and antianxiety benzodiazepines"
family: "51400000"
familyTitle: "Tranquilizers and antimanic and antianxiety drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Reclazepam

**UNSPSC Code**: 51401548
**Class**: [Tranquilizers and antimanic and antianxiety benzodiazepines](Tranquilizers and antimanic and antianxiety benzodiazepines.mdx)
**Family**: [Tranquilizers and antimanic and antianxiety drugs](../Tranquilizers and antimanic and antianxiety drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anxiolytic with the molecular formula C18H13Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YJL42911RA, chemically known as 4(5h)-oxazolone, 2-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1h-1,4-benzodiazepin-1-yl)-; but generally known as reclazepam, which bears US NIH Compound Identifier 3052777. European Medicines Agency schedules Reclazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10269MIG. The term RECLAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). RECLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule reclazepam under HS 29349990 and SITC 51579. As of Q4 2014, RECLAZEPAM remains the US FDA Preferred Term for this commodity. Reclazepam bears US NLM identifiers UMLS ID C2347902 and NCI Concept Code C74186. SMILES: CLC1CC2C(N(CCN=C2C2C(CL)CCCC2)C2=NC(=O)CO2)CC1.

